Published: Oct 23, 2025, 23:23 IST | Updated: Oct 23, 2025, 23:23 IST
A global clinical trial involving more than 17,000 participants has revealed that the weight-loss drug Ozempic can dramatically reduce the risk of heart attacks and strokes — even in patients who don’t lose weight. Researchers say the findings could redefine the treatment of heart disease and reshape global cardiovascular care, marking a breakthrough moment in preventive medicine.